EMA
approval
· 2021-05-21
New treatment for obesity caused by rare genetic disorders
Summary
EMA announces a new treatment for obesity associated with rare genetic disorders, expanding options for this patient population.
Upgrade for the full analysis, importance score, and drug timeline.